normatec pcd pneumatic compression device

Results: Both subjects demonstrated improvement in exercise duration time, peak oxygen volume, and ventilator threshold, as compared to the baseline evaluation.Ĭonclusions: These findings are promising and provide the foundation for future studies that will focus on increasing study participation (sample size) to better assess the clinical benefit of compression therapy for Fontan patients.

Subjects were then re-evaluated with a final treadmill stress test and data acquisition of new cardiorespiratory parameters. After training, test subjects conducted 6 days of external compression therapy at-home. Following an initial health screening, test subjects were pre-evaluated with a modified-Bruce treadmill exercise stress test, and baseline data on cardiorespiratory health was collected. This device is composed of inflatable trouser compartments that facilitate circumferentially and uniformly applied pressure to a patient’s lower extremities. Methods: To initially evaluate this hypothesis, we employed the NormaTec pneumatic compression device (PCD) in a pilot clinical study (n=2). Our hypothesis is that routinely administered, externally applied compression treatments to the lower extremities will augment systemic venous return, improve ventricular preload, and thus enhance cardiac output in Fontan patients. This study describes the evaluation of an alternative, non-invasive, at-home therapeutic compression treatment for Fontan patients.

Interviews with Outstanding Guest Editorsīackground: Limited therapeutic options are available for Fontan patients with dysfunctional or failing single ventricle physiology.

Policy of Dealing with Allegations of Research Misconduct.

Policy of Screening for Plagiarism Process.

Normatec pcd pneumatic compression device